Baolingbao Biology Co Ltd (002286) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.061x

Based on the latest financial reports, Baolingbao Biology Co Ltd (002286) has a cash flow conversion efficiency ratio of 0.061x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥134.96 Million ≈ $19.75 Million USD) by net assets (CN¥2.20 Billion ≈ $322.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Baolingbao Biology Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Baolingbao Biology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Baolingbao Biology Co Ltd (002286) total liabilities for a breakdown of total debt and financial obligations.

Baolingbao Biology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Baolingbao Biology Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Nel ASA OL:NEL	-0.023x
China Steel Chemical Corp TW:1723	0.052x
DRB - Hicom Bhd KLSE:1619	0.037x
Yinchuan Xinhua Commercial Group Co Ltd SHG:600785	0.170x
Entero Healthcare Solutions Ltd. NSE:ENTERO	-0.023x
Telefonica Chile S.A. SN:CTC	-0.101x
VGI Public Company Limited BK:VGI	0.002x
Oxford Industries Inc NYSE:OXM	-0.017x

Annual Cash Flow Conversion Efficiency for Baolingbao Biology Co Ltd (2006–2024)

The table below shows the annual cash flow conversion efficiency of Baolingbao Biology Co Ltd from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see 002286 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.04 Billion ≈ $298.74 Million	CN¥248.72 Million ≈ $36.40 Million	0.122x	-14.39%
2023-12-31	CN¥1.98 Billion ≈ $290.25 Million	CN¥282.28 Million ≈ $41.31 Million	0.142x	+825.49%
2022-12-31	CN¥2.00 Billion ≈ $293.30 Million	CN¥30.82 Million ≈ $4.51 Million	0.015x	-86.48%
2021-12-31	CN¥1.81 Billion ≈ $265.33 Million	CN¥206.27 Million ≈ $30.18 Million	0.114x	-54.34%
2020-12-31	CN¥1.60 Billion ≈ $234.04 Million	CN¥398.46 Million ≈ $58.31 Million	0.249x	+153.58%
2019-12-31	CN¥1.57 Billion ≈ $229.30 Million	CN¥153.95 Million ≈ $22.53 Million	0.098x	+13.86%
2018-12-31	CN¥1.54 Billion ≈ $225.64 Million	CN¥133.05 Million ≈ $19.47 Million	0.086x	+456.56%
2017-12-31	CN¥1.53 Billion ≈ $223.17 Million	CN¥-36.91 Million ≈ $-5.40 Million	-0.024x	-133.49%
2016-12-31	CN¥1.51 Billion ≈ $220.69 Million	CN¥108.98 Million ≈ $15.95 Million	0.072x	+37.85%
2015-12-31	CN¥1.48 Billion ≈ $216.29 Million	CN¥77.49 Million ≈ $11.34 Million	0.052x	-25.34%
2014-12-31	CN¥1.45 Billion ≈ $212.09 Million	CN¥101.77 Million ≈ $14.89 Million	0.070x	+17.74%
2013-12-31	CN¥1.44 Billion ≈ $210.03 Million	CN¥85.60 Million ≈ $12.53 Million	0.060x	-48.22%
2012-12-31	CN¥817.45 Million ≈ $119.62 Million	CN¥94.15 Million ≈ $13.78 Million	0.115x	-48.98%
2011-12-31	CN¥760.53 Million ≈ $111.29 Million	CN¥171.70 Million ≈ $25.12 Million	0.226x	+478.31%
2010-12-31	CN¥703.11 Million ≈ $102.89 Million	CN¥27.45 Million ≈ $4.02 Million	0.039x	-41.88%
2009-12-31	CN¥662.61 Million ≈ $96.96 Million	CN¥44.51 Million ≈ $6.51 Million	0.067x	-85.56%
2008-12-31	CN¥238.05 Million ≈ $34.83 Million	CN¥110.77 Million ≈ $16.21 Million	0.465x	+13.88%
2007-12-31	CN¥193.28 Million ≈ $28.28 Million	CN¥78.98 Million ≈ $11.56 Million	0.409x	+140.46%
2006-12-31	CN¥112.53 Million ≈ $16.47 Million	CN¥19.12 Million ≈ $2.80 Million	0.170x	--

About Baolingbao Biology Co Ltd

SHE:002286 China Biotechnology

Market Cap

$572.48 Million

CN¥3.91 Billion CNY

Market Cap Rank

#11840 Global

#3630 in China

Share Price

CN¥10.28

Change (1 day)

+1.08%

52-Week Range

CN¥8.74 - CN¥12.87

All Time High

CN¥23.40